Skip to content

'Questions About Quitting' Smoking Cessation Trial

Optimizing an Online Motivational Tobacco Cessation Program

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00992264
Acronym
Q2
Enrollment
1865
Registered
2009-10-09
Start date
2010-05-31
Completion date
2013-11-30
Last updated
2017-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

Cigarette Smoking, Health Behavior, Intervention Studies, Personal Communication

Brief summary

The current study tested the effectiveness of four potentially important tailoring factors (decisional framework, self-efficacy, navigation autonomy, and proactive outreach) in the context of an online motivational intervention for smoking cessation. A fifth factor was originally planned by dropped during intervention development due to confounds with the other planned factors. Information learned from this study will inform how to best design an online interventions for smoking cessation. Participants were recruited from a large, regional U.S. health plan. Using a full factorial design to screen for important main effects and 2-way interactions, participants were randomized to receive one of 16 different experimental factor combinations and followed for one year to assess program impact on smokers' use of empirically-validated cessation treatment and abstinence.

Detailed description

The current study is a factorial screening experiment, consistent with the Multiphase Optimization Strategy. Participants were randomly assigned to one of 16 different combinations of the 4 experimental factors. Each factor was explored on 2 contrasting levels. Each contrasting factor level was then compared to the other, resulting in 4 analytic arms. Within each arm, all participants (n = 1865) were analyzed to determine the relative effect of each contrasting factor level on the primary and secondary outcomes of interest.

Interventions

BEHAVIORALMessage Tone

All participants receive an tailored, online smoking cessation program. Participants in this intervention group either receive content written in a prescriptive tone or a motivational tone.

BEHAVIORALNavigation

Persons in this arm either have their ability to navigate the site dictated for them based on their readiness to quit smoking or they are able to freely navigate through the website.

Persons receive periodic, proactively delivered email reminders to visit the intervention website.

BEHAVIORALTestimonials

People receive a personally-tailored testimonial as part of their online smoking cessation program.

Sponsors

University of Michigan
CollaboratorOTHER
Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Member of Group Health Cooperative * Currently Smoking at Least 5 Cigarettes/Day * Access to Email and the Internet * Read and Write English * 18 years or older * Not currently receiving tobacco cessation treatment * Capable of participating in online and phone surveys

Exclusion criteria

* Persons will be excluded if they do not meet above criteria

Design outcomes

Primary

MeasureTime frameDescription
Smoking Abstinence12 months7 day point prevalent abstinence
Treatment Utilization for Smoking Cessation12 monthsconfirmed use of pharmacotherapy or enrollment in health plan-sponsored counseling program

Countries

United States

Participant flow

Recruitment details

Participants were recruited from Group Health, a large, non-profit health plan in the US Pacific Northwest. Data were collected between May 2010 and November 2012. All intervention and data collection occurred online.

Participants by arm

ArmCount
Randomization Arm: 1
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[dictated\], proactive emails \[yes\], and testimonials \[yes\].
116
Radndomization Arm: 2
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[not dictated\], proactive emails \[yes\], and testimonials \[yes\].
116
Randomization Arm: 3
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[dictated\], proactive emails \[no\], and testimonials \[yes\].
117
Randomization Arm: 4
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[not dictated\], proactive emails \[no\], and testimonials \[yes\].
117
Randomization Arm: 5
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[dictated\], proactive emails \[yes\], and testimonials \[no\].
117
Randomization Arm: 6
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[not dictated\], proactive emails \[yes\], and testimonials \[no\].
117
Randomization Arm: 7
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[dictated\], proactive emails \[no\], and testimonials \[no\].
116
Randomization Arm: 8
Persons assigned to this arm received the following intervention combination: Tone \[prescriptive\], Navigation \[not dictated\], proactive emails \[no\], and testimonials \[no\].
117
Randomization Arm: 9
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[dictated\], proactive emails \[yes\], and testimonials \[yes\].
116
Randomization Arm: 10
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[not dictated\], proactive emails \[yes\], and testimonials \[yes\].
116
Randomization Arm: 11
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[dictated\], proactive emails \[no\], and testimonials \[yes\].
117
Randomization Arm: 12
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[not dictated\], proactive emails \[no\], and testimonials \[yes\].
117
Randomization Arm: 13
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[dictated\], proactive emails \[yes\], and testimonials \[no\].
116
Randomization Arm: 14
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[not dictated\], proactive emails \[yes\], and testimonials \[no\].
117
Randomization Arm: 15
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[dictated\], proactive emails \[no\], and testimonials \[no\].
117
Randomization Arm: 16
Persons assigned to this arm received the following intervention combination: Tone \[motivational\], Navigation \[not dictated\], proactive emails \[no\], and testimonials \[no\].
116
Total1,865

Baseline characteristics

CharacteristicRadndomization Arm: 2Randomization Arm: 3Randomization Arm: 4Randomization Arm: 5Randomization Arm: 6Randomization Arm: 7Randomization Arm: 8Randomization Arm: 9Randomization Arm: 1Randomization Arm: 10Randomization Arm: 11Randomization Arm: 12Randomization Arm: 13Randomization Arm: 14Randomization Arm: 15Randomization Arm: 16Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
8 Participants7 Participants6 Participants7 Participants6 Participants8 Participants9 Participants8 Participants5 Participants4 Participants8 Participants6 Participants2 Participants4 Participants7 Participants7 Participants102 Participants
Age, Categorical
Between 18 and 65 years
108 Participants110 Participants111 Participants110 Participants111 Participants108 Participants108 Participants108 Participants111 Participants112 Participants109 Participants111 Participants114 Participants113 Participants110 Participants109 Participants1763 Participants
Age, Continuous44.06 years
STANDARD_DEVIATION 14.95
42.83 years
STANDARD_DEVIATION 15.06
45.93 years
STANDARD_DEVIATION 13.82
43.49 years
STANDARD_DEVIATION 14.34
43.84 years
STANDARD_DEVIATION 14.39
45.19 years
STANDARD_DEVIATION 14.6
44.33 years
STANDARD_DEVIATION 15.05
44.56 years
STANDARD_DEVIATION 15.43
43.34 years
STANDARD_DEVIATION 14.5
43.82 years
STANDARD_DEVIATION 14.24
46.09 years
STANDARD_DEVIATION 14.75
45.03 years
STANDARD_DEVIATION 14.26
42.29 years
STANDARD_DEVIATION 15.07
43.69 years
STANDARD_DEVIATION 14.95
44.39 years
STANDARD_DEVIATION 14.95
43.99 years
STANDARD_DEVIATION 14.97
44.2 years
STANDARD_DEVIATION 14.7
Region of Enrollment
United States
116 participants117 participants117 participants117 participants117 participants116 participants117 participants116 participants116 participants116 participants117 participants117 participants116 participants117 participants117 participants116 participants1865 participants
Sex: Female, Male
Female
79 Participants76 Participants66 Participants39 Participants76 Participants73 Participants69 Participants74 Participants75 Participants77 Participants72 Participants76 Participants65 Participants69 Participants76 Participants77 Participants1139 Participants
Sex: Female, Male
Male
37 Participants41 Participants51 Participants78 Participants41 Participants43 Participants48 Participants42 Participants41 Participants39 Participants45 Participants41 Participants51 Participants48 Participants41 Participants39 Participants726 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 1,8650 / 1,8650 / 1,8650 / 1,865
serious
Total, serious adverse events
0 / 1,8650 / 1,8650 / 1,8650 / 1,865

Outcome results

Primary

Smoking Abstinence

7 day point prevalent abstinence

Time frame: 12 months

Population: Missing data imputed, so all enrolled participants were included in the final intent to treat analytic sample.

ArmMeasureGroupValue (NUMBER)
Message Tone: PrescriptiveSmoking AbstinenceSmoking prevalence: 'active' intervention grp13.0 percentage of abstinent participants
Message Tone: PrescriptiveSmoking Abstinencesmoking prevalence: comparison group14.5 percentage of abstinent participants
TestimonialsSmoking Abstinencesmoking prevalence: comparison group13.6 percentage of abstinent participants
TestimonialsSmoking AbstinenceSmoking prevalence: 'active' intervention grp13.8 percentage of abstinent participants
Navigation: DictatedSmoking AbstinenceSmoking prevalence: 'active' intervention grp14.5 percentage of abstinent participants
Navigation: DictatedSmoking Abstinencesmoking prevalence: comparison group13.0 percentage of abstinent participants
Proactive OutreachSmoking AbstinenceSmoking prevalence: 'active' intervention grp13.3 percentage of abstinent participants
Proactive OutreachSmoking Abstinencesmoking prevalence: comparison group14.2 percentage of abstinent participants
Comparison: Comparison of persons assigned to Prescriptive message tone (n = 932) against persons assigned to Motivational message tone (n = 933).95% CI: [0.51, 1.51]
Comparison: Comparison of persons assigned to Testimonials (n = 933) against persons assigned to receive no testimonials (n = 932).95% CI: [0.66, 1.91]
Comparison: Comparison of persons assigned to the Dictated Navigation arm (n = 934) against persons assigned to assigned free navigation of the website (n = 931).95% CI: [0.7, 2.02]
Comparison: Comparison of persons assigned to Proactive Email Outreach (n = 933) against persons assigned to receive No Proactive Email Outreach (n = 932).95% CI: [0.43, 1.3]
Primary

Treatment Utilization for Smoking Cessation

confirmed use of pharmacotherapy or enrollment in health plan-sponsored counseling program

Time frame: 12 months

Population: Twenty-seven participants were excluded for not being enrolled in the health plan during the study period and not having access to the provided adjunct treatment.

ArmMeasureGroupValue (NUMBER)
Message Tone: PrescriptiveTreatment Utilization for Smoking CessationTreatment utilization: % in active intervention26.1 % of participants using adjunct treatmen
Message Tone: PrescriptiveTreatment Utilization for Smoking Cessationtreatment utilization: % in comparison group25.8 % of participants using adjunct treatmen
TestimonialsTreatment Utilization for Smoking Cessationtreatment utilization: % in comparison group26.6 % of participants using adjunct treatmen
TestimonialsTreatment Utilization for Smoking CessationTreatment utilization: % in active intervention25.3 % of participants using adjunct treatmen
Navigation: DictatedTreatment Utilization for Smoking CessationTreatment utilization: % in active intervention26.0 % of participants using adjunct treatmen
Navigation: DictatedTreatment Utilization for Smoking Cessationtreatment utilization: % in comparison group25.9 % of participants using adjunct treatmen
Proactive OutreachTreatment Utilization for Smoking CessationTreatment utilization: % in active intervention23.7 % of participants using adjunct treatmen
Proactive OutreachTreatment Utilization for Smoking Cessationtreatment utilization: % in comparison group28.2 % of participants using adjunct treatmen
Comparison: Comparison of persons assigned to Prescriptive message tone (n = 932) against persons assigned to Motivational message tone (n = 933).95% CI: [0.62, 1.43]
Comparison: Comparison of persons assigned to Testimonials (n = 933) against persons assigned to receive no testimonials (n = 932).95% CI: [0.46, 1.07]
Comparison: Comparison of persons assigned to the Dictated Navigation arm (n = 934) against persons assigned to assigned free navigation of the website (n = 931).95% CI: [0.51, 1.18]
Comparison: Comparison of persons assigned to Proactive Email Outreach (n = 933) against persons assigned to receive No Proactive Email Outreach (n = 932).95% CI: [0.44, 1.03]

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026